ASP Isotopes & Soligenix Inc.: Lead Innovators in Isotope Enrichment and Rare Diseases

Save
2 years ago
3
Isotope enrichment technology development South Africa Molybdenum-100 Molybdenum-99 replacement Soligenix biopharmaceutical company rare disease treatments Specialized BioTherapeutics HyBryte™ for CTCL Phase 3 study

This week’s episode of the RedChip Money Report includes interviews with senior executives from ASP Isotopes (NASDAQ: ASPI) & Soligenix Inc. (NASDAQ: SNGX). Visit RedChip.com to learn more. https://bit.ly/3PSQ63t

Loading comments...